Stay updated on Pembrolizumab for Bladder Cancer Surgery Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Bladder Cancer Surgery Clinical Trial page.

Latest updates to the Pembrolizumab for Bladder Cancer Surgery Clinical Trial page
- Check3 days agoChange DetectedThe page's revision tag is updated from v3.5.3 to v3.5.4, indicating a minor software revision for the site. This does not change the study content or layout visible to users.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3 on the page, indicating a minor update to the study record's documentation/versioning metadata.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedSite revision label updated to v3.5.2 and the previous v3.5.0 label removed.SummaryDifference0.1%

- Check60 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No visible changes to the study page content or core details.SummaryDifference0.1%

- Check67 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. No study data or page content were changed.SummaryDifference0.1%

- Check96 days agoChange DetectedA new site revision notice (Revision: v3.4.2) was added, and prior maintenance notices about government funding and operating status were removed; these updates do not affect the study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab for Bladder Cancer Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Bladder Cancer Surgery Clinical Trial page.